A Bentham Science kiadó egy új, tematikus folyóiratot indít. Az lesz a címe, hogy Coronaviruses. A főszerkesztő egy wuhani kutató.
D. Liu – Wuhan Institute of Virology, Wuhan (China)
Egy nobel-díjas személy is van a szerkesztők között: Prof. Ferid Murad, (USA)
Tartalomból (free content):
- Atta-ur-Rahman. (2020). Foreword. Coronaviruses, 1(1), 3–3. https://doi.org/10.2174/266679670101200806094013
- Banday, A. H., Shah, S. A., & Ajaz, S. J. (2020). Potential Immunotherapy against SARS-CoV-2: Strategy and Status. Coronaviruses, 1(1), 23–31. https://doi.org/10.2174/2666796701999200625212040
- Barupal, T., Tak, P. K., & Meena, M. (2020). COVID-19: Morphology, Characteristics, Symptoms, Prevention, Clinical Diagnosis and Current Scenario. Coronaviruses, 1(1), 82–89. https://doi.org/10.2174/2666796701999200617161348
- Bhatia, R., Narang, R. K., & Rawal, R. K. (2020). Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools. Coronaviruses, 1(1), 108–116. https://doi.org/10.2174/2666796701999200617155629
- Catalano, A. (2020). COVID-19: Could Irisin Become the Handyman Myokine of the 21st Century? Coronaviruses, 1(1), 32–41. https://doi.org/10.2174/2666796701999200617154655
- Doshi, G. M., Ved, H. S., & Thakkar, A. P. (2020). Critical Insight into the Attributes of Emerging Novel Coronavirus (COVID-19) in India and Across the World. Coronaviruses, 1(1), 49–56. https://doi.org/10.2174/2666796701999200623172631
- Kalirajan, R. (2020). Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach. Coronaviruses, 1(1), 13–22. https://doi.org/10.2174/2666796701999200625210746
- Katta, M., Rapaka, S., Adireddi, R., & Emandi, J. R. (2020). A Preliminary Review on Novel Coronavirus Disease: COVID-19. Coronaviruses, 1(1), 90–97. https://doi.org/10.2174/2666796701999200615155630
- Kebede, T., Kumar, D., & Sharma, P. K. (2020). Potential Drug Options for Treatment of COVID-19: A Review. Coronaviruses, 1(1), 42–48. https://doi.org/10.2174/2666796701999200701131604
- Momtaz, Y. A. (2020). The COVID-19 and Ageism in Social Media. Coronaviruses, 1(1), 7–8. https://doi.org/10.2174/2666796701999200621203144
- Murad, F. (2020). Foreword. Coronaviruses, 1(1), 2–2. https://doi.org/10.2174/266679670101200806093911
- Naqvi, I. H., & Rizvi, S. N. Z. (2020). The Comprehensive Appraisal of COVID-19: Its’ Clinical Panorama from Virology till Management and Beyond. Coronaviruses, 1(1), 57–72. https://doi.org/10.2174/2666796701999200701132336
- Raj, S., Chandel, V., Rathi, B., & Kumar, D. (2020). Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach. Coronaviruses, 1(1), 73–81. https://doi.org/10.2174/2666796701999200617155013
- Sabatier, J.-M. (2020). Preface. Coronaviruses, 1(1), 1–1. https://doi.org/10.2174/266679670101200806093737
- Sivaraman, D., Pradeep, P. S., Manoharan, S. S., Bhat, C. R., Leela, K. V., & Venugopal, V. (2020). Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19. Coronaviruses, 1(1), 98–107. https://doi.org/10.2174/2666796701999200701122817
- Strongin, A. Y., Sloutsky, A., & Cieplak, P. (2020). A Note on the Potential BCG Vaccination – COVID-19 Molecular Link. Coronaviruses, 1(1), 4–6. https://doi.org/10.2174/2666796701999200629003417
- Varala, R., & Bollikolla, H. (2020). nCovid-19 in 2020: From Despair to Hope. Coronaviruses, 1(1), 9–12. https://doi.org/10.2174/2666796701999200621202839
AIMS & SCOPE
Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.
The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.